USAAdd to My Companies | Give a Referral for this Company | Print this Profile
The latest news, announcements and press releases from Nexus Pharmaceuticals.
PLEASANT PRAIRIE, WI.–Nexus Pharmaceuticals Inc. plans to complete its nearly $100 million Pleasant Prairie sterile injectables plant in April 2021 and a company executive said it will help address the United States’ reliance on foreign pharmaceutical suppliers magnified by the Covid-19 pandemic.
Privately held Nexus Pharmaceuticals, of Lincolnshire, Illinois, announced in July 2019 that the first phase of its multi-year project would open in 2021 but didn’t specify an opening timeframe. Production should be underway in the facility by early 2022 with 77 employees working there, said chief financial officer Usman Ahmed.
“It’s going good — so far so good,” Ahmed said of the project.
The three-story, 84,000-square-foot facility is being built in the Prairie Highlands Corporate Park, which is west of Interstate 94 across from LakeView Corporate Park and next to a new Aurora Health Care complex. The total project cost is just under $100 million including construction, real estate and equipment, Ahmed said.
This is the News section of the company profile page for Nexus Pharmaceuticals on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.